IMMX Insider Trading Activity and SEC Form 4 Filings
IMMX insider trading summary
Over the past 12 months, insiders at Immix Biopharma, Inc. (IMMX) reported 2 open-market purchases worth $10K by 2 insiders and no sales on SEC Form 4. Net insider buying was $10K.
Latest IMMX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 10, 2025 | Ilya M Rachman | CEO and Chairman | Buy | $5K (746 @ $6.67) |
| Dec 10, 2025 | Gabriel S Morris | CFO | Buy | $5K (770 @ $6.58) |
| Sep 17, 2025 | Ilya M Rachman | CEO and Chairman | Buy | $5K (2,500 @ $2.02) |
| Sep 16, 2025 | Gabriel S Morris | CFO | Buy | $5K (2,600 @ $1.97) |
| Jun 18, 2025 | Gabriel S Morris | CFO | Buy | $5K (2,225 @ $2.28) |
| Jun 18, 2025 | Ilya M Rachman | CEO and Chairman | Buy | $5K (2,178 @ $2.29) |
| Dec 23, 2024 | Jason Hsu | Director | Buy | $88K (40,000 @ $2.19) |
| Dec 20, 2024 | Jason Hsu | Director | Buy | $17K (7,700 @ $2.17) |
| Aug 22, 2024 | Jason Hsu | Director | Buy | $18K (8,100 @ $2.25) |
| Aug 21, 2024 | Jason Hsu | Director | Buy | $33K (15,000 @ $2.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.